USPTO trademark

TRINQUIS

AllowedUSPTOWord markClass 5

"TRINQUIS" is a word mark owned by Teva Pharmaceuticals USA, Inc., filed at the USPTO on April 19, 2023. It has been allowed and covers class 5 (Pharmaceuticals).

View Teva Pharmaceuticals USA, Inc. portfolioGet this data via the API
Official USPTO record
TRINQUIS trademark as filed
As filed with the USPTO
Status
Allowed
Since October 14, 2026
Filed
April 19, 2023
Registered
Not yet
Expires
Not recorded
Application no.
97896222
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns TRINQUIS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceuticals USA, Inc.

Parsippany, United States

648 trademarks in the portfolioView company

Representative

Lori Wolfe

Teva Pharmaceuticals USA, Inc.

Goods and services

What the mark covers

The products and services TRINQUIS is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 4 granted
  3. Case assigned to intent to use paralegal
  4. Sou extension received with teas petition
  5. Notice of revival - e-mailed
  6. Petition to revive-granted
  7. Teas petition to revive received
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

10 earlier steps on the official record.

FAQ

About TRINQUIS

Who owns the trademark "TRINQUIS"?

The USPTO trademark "TRINQUIS" (application 97896222) is owned by Teva Pharmaceuticals USA, Inc.

What is the status of "TRINQUIS"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TRINQUIS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b9c-d65c-72cc-a296-19a3d7328975
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b9c-d65c-72cc-a296-19a3d7328975",
  "object": "trademark",
  "mark_text": "TRINQUIS",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97896222",
  "filing_date": "2023-04-19",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "TEVA PHARMACEUTICALS USA, Inc.",
      "entity_id": "ent_019fc41c-ecc5-76e9-863d-e500c53224ec"
    }
  ]
}